ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Alzheimer's: safety trial of Add-On therapy begins
Symptom relief Not yet recruitingThis study tests whether adding an experimental drug (X/T+X-EC) to standard Alzheimer's treatment (lecanemab) is safe and tolerable. About 60 adults with Alzheimer's will receive either the drug or a placebo for 24 weeks. The main goal is to check for side effects, not to measure…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2 • Sponsor: Neurology Office of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can Real-World data uncover hidden risks of the Alzheimer's drug LEQEMBI?
Knowledge-focused Not yet recruitingThis registry study follows 400 Alzheimer's patients in Canada who are prescribed LEQEMBI, a medication for the disease. The goal is to track the frequency and severity of known side effects, such as brain swelling (ARIA-E), microbleeds (ARIA-H), and larger brain hemorrhages, dur…
Matched conditions: ALZHEIMERS DISEASE
Sponsor: Eisai Limited • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC